Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-19 | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira
(EVP, Chief Financial Officer) |
F | Common Stock | D | 1122 | $2.64 - $2.64 | $2,962 |
2024-01-19 | HERON THERAPEUTICS, INC. /DE/ | Christian Waage
(Director) |
A | Common Stock | A | 13948 | $0.00 - $0.00 | $0 |
2024-01-19 | HERON THERAPEUTICS, INC. /DE/ | Rodriguez Susan
(Director) |
A | Common Stock | A | 13948 | $0.00 - $0.00 | $0 |
2024-01-19 | HERON THERAPEUTICS, INC. /DE/ | Morgan Adam
(Director) |
A | Common Stock | A | 13948 | $0.00 - $0.00 | $0 |
2024-01-19 | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A
(Director) |
A | Common Stock | A | 13948 | $0.00 - $0.00 | $0 |
2024-01-19 | HERON THERAPEUTICS, INC. /DE/ | Dissanaike Sharmila
(Director) |
A | Common Stock | A | 13948 | $0.00 - $0.00 | $0 |
2024-01-13 | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa
(VP, Chief Accounting Officer) |
F | Common Stock | D | 756 | $2.15 - $2.15 | $1,625 |
2023-11-17 | HERON THERAPEUTICS, INC. /DE/ | Forbes William P
(EVP, Chief Development Officer) |
P | Common Stock | A | 25000 | $1.09 - $1.09 | $27,250 |
2023-11-16 | HERON THERAPEUTICS, INC. /DE/ | Forbes William P
(EVP, Chief Development Officer) |
P | Common Stock | A | 50000 | $0.94 - $0.94 | $46,995 |
2023-11-16 | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A
(Chief Executive Officer) |
P | Common Stock | A | 150000 | $0.92 - $0.92 | $137,970 |
2023-11-16 | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira
(EVP, Chief Financial Officer) |
P | Common Stock | A | 85000 | $0.89 - $0.89 | $75,599 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |